Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
264.42 USD | -1.93% |
|
+3.35% | +43.15% |
12/06 | Sector Update: Health Care Stocks Lean Lower Premarket Thursday | MT |
12/06 | BeOne Medicines Ltd Showcases Breakthrough Data in CLL and MCL at EHA 2025 | CI |
Capitalization | 3.37TCr 2.92TCr 2.74TCr 2.48TCr 4.57TCr 2,89000Cr 5.16TCr 32TCr 12TCr 1,32600Cr 13TCr 12TCr 4,87500Cr | P/E ratio 2025 * |
169x | P/E ratio 2026 * | 39.9x |
---|---|---|---|---|---|
Enterprise value | 3.19TCr 2.76TCr 2.6TCr 2.35TCr 4.33TCr 2,73600Cr 4.89TCr 30TCr 12TCr 1,25500Cr 12TCr 12TCr 4,61500Cr | EV / Sales 2025 * |
6.25x | EV / Sales 2026 * | 5.05x |
Free-Float |
96.17% | Yield 2025 * |
-
| Yield 2026 * | - |
More valuation ratios
* Estimated data
More news
Last Transcript: BeOne Medicines Ltd.
More recommendations
More press releases
More news
1 day | -1.93% | ||
1 week | +3.35% | ||
Current month | +7.67% | ||
1 month | +17.12% | ||
3 months | +2.02% | ||
6 months | +47.43% | ||
Current year | +43.15% |
1 week | 257.41 | ![]() | 284.51 |
1 month | 228.92 | ![]() | 284.51 |
Current year | 172.67 | ![]() | 287.88 |
1 year | 141.31 | ![]() | 287.88 |
3 years | 124.46 | ![]() | 287.88 |
5 years | 118.18 | ![]() | 426.56 |
10 years | 22.51 | ![]() | 426.56 |
Manager | Title | Age | Since |
---|---|---|---|
John Oyler
CEO | Chief Executive Officer | 56 | 28/10/2010 |
Xiao Bin Wu
PSD | President | 63 | 01/04/2018 |
Aaron Rosenberg
DFI | Director of Finance/CFO | 49 | 22/07/2024 |
Director | Title | Age | Since |
---|---|---|---|
John Oyler
CHM | Chairman | 56 | 27/01/2016 |
Michael Goller
BRD | Director/Board Member | 50 | 01/04/2015 |
Ranjeev Krishana
BRD | Director/Board Member | 51 | 01/10/2014 |
Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
---|---|---|---|---|---|---|
-1.93% | +3.35% | +62.64% | +93.37% | 3.44TCr | ||
-1.24% | +5.97% | -49.57% | -6.86% | 5.59TCr | ||
-3.88% | -6.41% | +33.86% | +48.33% | 3.55TCr | ||
+0.28% | +6.97% | +56.66% | -28.41% | 2.74TCr | ||
-0.23% | -1.99% | +15.48% | -22.94% | 2.56TCr | ||
+2.90% | +37.99% | +58.93% | +470.73% | 1.88TCr | ||
+0.86% | -3.11% | +137.78% | +1,922.30% | 1.47TCr | ||
-5.36% | +7.51% | +125.72% | -61.03% | 1.45TCr | ||
-0.44% | +2.01% | -19.54% | -24.81% | 1.41TCr | ||
+0.38% | -2.97% | +92.04% | +132.72% | 1.13TCr | ||
Average | -0.87% | +5.67% | +51.40% | +252.34% | 2.52TCr | |
Weighted average by Cap. | -1.13% | +5.47% | +32.72% | +160.60% |
2025 * | 2026 * | |
---|---|---|
Net sales | 510.17Cr 441.37Cr 415.08Cr 375.72Cr 692.25Cr 44TCr 781.91Cr 4.84TCr 1.89TCr 20TCr 1.91TCr 1.87TCr 74TCr | 617.12Cr 533.9Cr 502.09Cr 454.49Cr 837.38Cr 53TCr 945.83Cr 5.85TCr 2.28TCr 24TCr 2.32TCr 2.27TCr 89TCr |
Net income | 13Cr 11Cr 11Cr 9.6Cr 18Cr 1.12TCr 20Cr 123.65Cr 48Cr 512.84Cr 49Cr 48Cr 1.89TCr | 60Cr 52Cr 49Cr 44Cr 82Cr 5.17TCr 92Cr 571.48Cr 222.58Cr 2.37TCr 225.98Cr 221.2Cr 8.71TCr |
Net Debt | -179.36Cr -155.17Cr -145.93Cr -132.1Cr -243.38Cr -15TCr -274.9Cr -1.7TCr -662.78Cr -7.06TCr -672.9Cr -658.66Cr -26TCr | -254.65Cr -220.31Cr -207.18Cr -187.54Cr -345.53Cr -22TCr -390.29Cr -2.42TCr -940.97Cr -10TCr -955.34Cr -935.12Cr -37TCr |
More financial data
* Estimated data
Employees
11,000
Calendar
26/06
- R&D Day
Date | Price | Change | Volume |
---|---|---|---|
16/25/16 | 264.42 $ | -1.93% | 3,26,595 |
13/25/13 | 269.63 $ | -2.50% | 3,91,803 |
12/25/12 | 276.53 $ | +5.38% | 7,24,422 |
11/25/11 | 262.41 $ | -0.38% | 2,82,617 |
10/25/10 | 263.42 $ | -0.14% | 4,16,173 |
Delayed Quote Nasdaq, June 17, 2025 at 01:30 am IST
More quotesSell
Buy

Mean consensus
BUY
Number of Analysts
24
Last Close Price
269.63USD
Average target price
331.97USD
Spread / Average Target
+23.12%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- ONC Stock
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition